Renu Wadhwa Selected Research

withaferin A

1/2024	Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl Ester.
7/2023	Effect of Withaferin-A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer Therapy.
1/2023	Three-Way Cell-Based Screening of Antistress Compounds: Identification, Validation, and Relevance to Old-Age-Related Pathologies.
1/2022	Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of p53 in cancer cells harbouring wild type and p53Ser46 mutant.
1/2022	Phosphatidylserine Exposed Lipid Bilayer Models for Understanding Cancer Cell Selectivity of Natural Compounds: A Molecular Dynamics Simulation Study.
1/2021	Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers.
11/2019	2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences.
2/2019	Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence.
10/2017	2,3-Dihydro-3β-methoxy Withaferin-A Protects Normal Cells against Stress: Molecular Evidence of Its Potent Cytoprotective Activity.
1/2017	Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renu Wadhwa Research Topics

Disease

89	Neoplasms (Cancer) 07/2023 - 08/2002
22	Neoplasm Metastasis (Metastasis) 05/2023 - 01/2004
16	Carcinogenesis 02/2021 - 01/2005
8	Breast Neoplasms (Breast Cancer) 06/2021 - 06/2006
7	AIDS-Related Complex (ARC) 01/2022 - 11/2013
7	Glioma (Gliomas) 02/2020 - 09/2009
5	Hypoxia (Hypoxemia) 01/2023 - 01/2018
5	Neuroblastoma 02/2020 - 01/2012
4	Inflammation (Inflammations) 09/2020 - 01/2012
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2020 - 01/2011
3	Parkinson Disease (Parkinson's Disease) 10/2021 - 07/2006
3	Amnesia (Dissociative Amnesia) 07/2016 - 01/2011
2	Virus Diseases (Viral Diseases) 01/2024 - 12/2023
2	COVID-19 01/2024 - 08/2021
2	Urticaria (Hives) 12/2021 - 07/2021
2	Cognitive Dysfunction 07/2021 - 09/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2020 - 12/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 07/2015
2	Memory Disorders (Memory Loss) 09/2019 - 01/2011
2	Melanoma (Melanoma, Malignant) 01/2019 - 07/2016
2	Keloid 10/2017 - 07/2016
2	Fibrosis (Cirrhosis) 10/2017 - 07/2015
2	Brain Diseases (Brain Disorder) 07/2016 - 01/2013
2	Glioblastoma (Glioblastoma Multiforme) 11/2010 - 09/2009
1	Disease Susceptibility (Diathesis) 01/2024

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2002
40	mortalinIBA 05/2023 - 06/2003
23	AshwagandhaIBA 01/2023 - 04/2007
17	withanoneIBA 07/2023 - 04/2008
13	withaferin AIBA 01/2024 - 09/2009
11	caffeic acid phenethyl esterIBA 01/2024 - 01/2018
9	Small Interfering RNA (siRNA)IBA 05/2018 - 10/2005
8	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2020 - 05/2007
7	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 08/2002
7	Catalytic RNA (Ribozymes)IBA 01/2012 - 06/2003
6	Propolis (Bee Bread)IBA 01/2024 - 03/2018
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 10/2014
5	WithanolidesIBA 10/2022 - 12/2014
5	Tumor Suppressor Protein p53IBA 01/2022 - 01/2009
5	PhytochemicalsIBA 01/2020 - 10/2009
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2019 - 01/2005
4	cucurbitacin BIBA 05/2023 - 01/2018
4	MetalsIBA 01/2023 - 02/2020
4	triethylene glycolIBA 01/2023 - 01/2017
4	CateninsIBA 02/2022 - 05/2018
4	artepillin CIBA 01/2022 - 07/2021
4	Indicators and Reagents (Reagents)IBA 02/2020 - 10/2010
4	Scopolamine (Hyoscine)FDA Link 09/2019 - 01/2011
4	MKT 077IBA 01/2017 - 08/2002
4	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2016 - 10/2011
4	glucose-regulated proteinsIBA 03/2015 - 01/2005
3	Messenger RNA (mRNA)IBA 12/2023 - 10/2011
3	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 03/2007
3	Matrix Metalloproteinases (MMPs)IBA 02/2022 - 10/2014
3	VimentinIBA 02/2022 - 11/2019
3	AntibodiesIBA 01/2022 - 05/2007
3	Peptides (Polypeptides)IBA 01/2022 - 09/2004
3	EnzymesIBA 12/2021 - 04/2004
3	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2011
3	Fibronectins (Fibronectin)IBA 01/2020 - 12/2004
3	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2015 - 09/2002
3	Coloring Agents (Dyes)IBA 03/2012 - 08/2002
2	Cadherins (E-Cadherin)IBA 02/2022 - 11/2019
2	Complementary DNA (cDNA)IBA 02/2022 - 01/2016
2	AntioxidantsIBA 07/2021 - 01/2012
2	Adenosine Triphosphate (ATP)IBA 06/2021 - 12/2019
2	PolymersIBA 06/2021 - 11/2007
2	Apoptosis Regulatory ProteinsIBA 08/2020 - 01/2019
2	Cyclin DIBA 01/2020 - 01/2019
2	Carotenoids (Carotene)IBA 06/2019 - 03/2019
2	fucoxanthinIBA 06/2019 - 03/2019
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2017 - 03/2015
2	Cholinergic Agents (Cholinergics)IBA 07/2016 - 01/2011
2	embelinIBA 01/2015 - 10/2014
2	Glutamic Acid (Glutamate)FDA Link 11/2013 - 01/2012
2	Cyclin D1IBA 01/2013 - 01/2013
2	rhodacyanineIBA 03/2012 - 08/2002
1	VaccinesIBA 01/2024
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2024
1	Androgen Receptors (Androgen Receptor)IBA 01/2024
1	Androgen Antagonists (Antiandrogens)IBA 01/2024
1	MethyltransferasesIBA 07/2023
1	cadmium nitrateIBA 01/2023
1	ParaquatIBA 01/2023
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2023
1	LigandsIBA 10/2022
1	Cell Surface ReceptorsIBA 10/2022
1	Angiotensin-Converting Enzyme 2IBA 10/2022
1	Tight Junction ProteinsIBA 02/2022
1	ClaudinsIBA 02/2022
1	Nucleic AcidsIBA 01/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2022
1	PhosphatidylserinesIBA 01/2022
1	LuciferasesIBA 12/2021
1	TubulinIBA 12/2021
1	Phenobarbital (Luminal)FDA Link 06/2021

Therapy/Procedure

29	Therapeutics 07/2023 - 01/2004
4	Quantum Dots (Quantum Dot) 11/2013 - 12/2003
3	Drug Therapy (Chemotherapy) 01/2018 - 10/2010